 Lymphoma, Large-Cell, Anaplastic
"Lymphoma, Large-Cell, Anaplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A systemic, large-cell, non-Hodgkin, malignant lymphoma characterized by cells with pleomorphic appearance and expressing the CD30 ANTIGEN. These so-called "hallmark" cells have lobulated and indented nuclei. This lymphoma is often mistaken for metastatic carcinoma and MALIGNANT HISTIOCYTOSIS.
| Descriptor ID |
D017728
|
| MeSH Number(s) |
C04.557.386.480.487 C04.557.386.480.750.399 C15.604.515.569.480.487 C20.683.515.761.480.750.399
|
| Concept/Terms |
Lymphoma, Large-Cell, Anaplastic- Lymphoma, Large-Cell, Anaplastic
- CD30-Positive Anaplastic Large-Cell Lymphoma
- CD30 Positive Anaplastic Large Cell Lymphoma
- Ki-1 Lymphoma
- Ki 1 Lymphoma
- Ki-1 Lymphomas
- Lymphoma, Ki-1
- Lymphomas, Ki-1
- Systemic Anaplastic Large-Cell Lymphoma
- Systemic Anaplastic Large Cell Lymphoma
- Anaplastic Large-Cell Lymphoma
- Anaplastic Large Cell Lymphoma
- Anaplastic Large-Cell Lymphomas
- Large-Cell Lymphoma, Anaplastic
- Large-Cell Lymphomas, Anaplastic
- Lymphoma, Anaplastic Large-Cell
- Lymphomas, Anaplastic Large-Cell
- CD30+ Anaplastic Large-Cell Lymphoma
- CD30+ Anaplastic Large Cell Lymphoma
- Lymphoma, Large-Cell, Ki-1
|
Below are MeSH descriptors whose meaning is more general than "Lymphoma, Large-Cell, Anaplastic".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Lymphoma [C04.557.386]
- Lymphoma, Non-Hodgkin [C04.557.386.480]
- Lymphoma, Large-Cell, Anaplastic [C04.557.386.480.487]
- Lymphoma, T-Cell [C04.557.386.480.750]
- Lymphoma, Large-Cell, Anaplastic [C04.557.386.480.750.399]
- Hemic and Lymphatic Diseases [C15]
- Lymphatic Diseases [C15.604]
- Lymphoproliferative Disorders [C15.604.515]
- Lymphoma [C15.604.515.569]
- Lymphoma, Non-Hodgkin [C15.604.515.569.480]
- Lymphoma, Large-Cell, Anaplastic [C15.604.515.569.480.487]
- Immune System Diseases [C20]
- Immunoproliferative Disorders [C20.683]
- Lymphoproliferative Disorders [C20.683.515]
- Lymphoma [C20.683.515.761]
- Lymphoma, Non-Hodgkin [C20.683.515.761.480]
- Lymphoma, T-Cell [C20.683.515.761.480.750]
- Lymphoma, Large-Cell, Anaplastic [C20.683.515.761.480.750.399]
Below are MeSH descriptors whose meaning is more specific than "Lymphoma, Large-Cell, Anaplastic".
This graph shows the total number of publications written about "Lymphoma, Large-Cell, Anaplastic" by people in UAMS Profiles by year, and whether "Lymphoma, Large-Cell, Anaplastic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2023 | 1 | 0 | 1 | | 2021 | 2 | 0 | 2 | | 2019 | 1 | 0 | 1 | | 2018 | 3 | 0 | 3 | | 2010 | 0 | 1 | 1 | | 2008 | 0 | 2 | 2 | | 2002 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Lymphoma, Large-Cell, Anaplastic" by people in Profiles over the past ten years.
-
Pina-Oviedo S, Motwani P. Composite ALK-negative anaplastic large-cell lymphoma and mantle cell lymphoma. Blood. 2023 02 02; 141(5):556.
-
Meawad H, Song JY, Ulrickson ML, Weisenburger DD. Primary Cutaneous Gamma-Delta T-Cell Lymphoma Mimicking anaplastic lymphoma kinase-1-Negative Anaplastic Large Cell Lymphoma: A Case Report. Am J Dermatopathol. 2022 Jan 01; 44(1):62-65.
-
Sasapu A, Dunn ALJ, Gardner J, Wong HK. Remission of refractory granulomatous primary cutaneous anaplastic large cell lymphoma to brentuximab vedotin. BMJ Case Rep. 2021 Jul 21; 14(7).
-
Evans MG, Medeiros LJ, Marques-Piubelli ML, Wang HY, Ortiz-Hidalgo C, Pina-Oviedo S, Morine A, Clemens MW, Hunt KK, Iyer S, Hu Q, Recavarren C, Demichelis R, Romero M, Sohani AR, Misialek M, Amin MB, Bueso-Ramos CE, Carballo-Zarate AA, Lee HJ, Ok CY, Xu J, Miranda RN. Breast implant-associated anaplastic large cell lymphoma: clinical follow-up and analysis of sequential pathologic specimens of untreated patients shows persistent or progressive disease. Mod Pathol. 2021 12; 34(12):2148-2153.
-
Lyapichev KA, Pi?a-Oviedo S, Medeiros LJ, Evans MG, Liu H, Miranda AR, Hunt KK, Clemens MW, Stewart JM, Amin MB, Quesada AE, Chai SM, Di Napoli A, Yoga A, Dave SK, Wistuba II, Wu Y, Bueso-Ramos CE, Schlette EJ, Ferrufino-Schmidt MC, Loghavi S, Khoury JD, Young KH, Miranda RN. A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma. Mod Pathol. 2020 03; 33(3):367-379.
-
Locatelli F, Mauz-Koerholz C, Neville K, Llort A, Beishuizen A, Daw S, Pillon M, Aladjidi N, Klingebiel T, Landman-Parker J, Medina-Sanson A, August K, Sachs J, Hoffman K, Kinley J, Song S, Song G, Zhang S, Suri A, Gore L. Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study. Lancet Haematol. 2018 Oct; 5(10):e450-e461.
-
Quesada AE, Medeiros LJ, Clemens MW, Ferrufino-Schmidt MC, Pina-Oviedo S, Miranda RN. Breast implant-associated anaplastic large cell lymphoma: a review. Mod Pathol. 2019 02; 32(2):166-188.
-
Ferrufino-Schmidt MC, Medeiros LJ, Liu H, Clemens MW, Hunt KK, Laurent C, Lofts J, Amin MB, Ming Chai S, Morine A, Di Napoli A, Dogan A, Parkash V, Bhagat G, Tritz D, Quesada AE, Pina-Oviedo S, Hu Q, Garcia-Gomez FJ, Jose Borrero J, Horna P, Thakral B, Narbaitz M, Hughes RC, Yang LJ, Fromm JR, Wu D, Zhang D, Sohani AR, Hunt J, Vadlamani IU, Morgan EA, Ferry JA, Szigeti R, C Tardio J, Granados R, Dertinger S, Offner FA, Pircher A, Hosry J, Young KH, Miranda RN. Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma. Am J Surg Pathol. 2018 03; 42(3):293-305.
|
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|